Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Green

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Experimental Zoology|January 1, 1985
On the use of alpha-amanitin as a transcriptional blocking agent in mouse embryos: a cautionary noteG M Kidder, A F Green, J R McLachlin
British Journal of Pharmacology|May 1, 1970
An antitussive test using guinea-pigsA L Boura, A F Green, I A Saunders
Experientia|January 15, 1972
Two new short-acting non-depolarizing neuromuscular blocking agentsF C Copp, G G Coker, A F Green, et al.
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1979
Autonomic pharmacology: report of the Main Working PartyA F Green, J M Armstrong, J B Farmer, et al.
Lancet (London, England)|May 24, 1975
Doxantrazole, an antiallergic agent orally effective in manJ F Batchelor, M J Follenfant, L G Garland, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Experimental Zoology|January 1, 1985
On the use of alpha-amanitin as a transcriptional blocking agent in mouse embryos: a cautionary noteG M Kidder, A F Green, J R McLachlin
British Journal of Pharmacology|May 1, 1970
An antitussive test using guinea-pigsA L Boura, A F Green, I A Saunders
Experientia|January 15, 1972
Two new short-acting non-depolarizing neuromuscular blocking agentsF C Copp, G G Coker, A F Green, et al.
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1979
Autonomic pharmacology: report of the Main Working PartyA F Green, J M Armstrong, J B Farmer, et al.
Lancet (London, England)|May 24, 1975
Doxantrazole, an antiallergic agent orally effective in manJ F Batchelor, M J Follenfant, L G Garland, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Pageof 2